EFFECTS OF RITUXIMAB IN THE TREATMENT OF SEVERE CRYOGLOBULINAEMIA

被引:0
|
作者
Roccatello, Dario [1 ]
Rossi, Daniela [2 ]
Baldovino, Simone [3 ]
Sena, Luigi Massimino [4 ]
机构
[1] Osped SG Bosco, Ctr Multidisciplinare Ric Immunopatol E Documenta, Turin, Italy
[2] Osped SG Bosco, Ctr Multidisciplinare Ric Immunopatol E Documenta, Struttura Complessa Direz Univ Immunol Clin CMID, Turin, Italy
[3] Osped G Bosco, CMID, Turin, Italy
[4] Univ Turin, Dipertimento Med & Oncol Sperimentale, I-10124 Turin, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A120 / A120
页数:1
相关论文
共 50 条
  • [41] Rituximab in severe, treatment-refractory interstitial lung disease
    Abdullah, Rezaur
    Ming, Damien
    Keir, Gregory
    Maher, Toby
    Wells, Athol
    Renzoni, Elisabetta
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [42] Severe neutropenia after rituximab-treatment of multiple sclerosis
    Rissanen, Eero
    Remes, Kari
    Airas, Laura
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 20 : 3 - 5
  • [43] Treatment of severe pemphigus with protein A immunoadsorption, rituximab and intravenous immunoglobulins
    Shimanovich, I.
    Nitschke, M.
    Rose, C.
    Grabbe, J.
    Zillikens, D.
    BRITISH JOURNAL OF DERMATOLOGY, 2008, 158 (02) : 382 - 388
  • [44] Rituximab for treatment of severe renal disease in ANCA associated vasculitis
    Geetha, Duvuru
    Hruskova, Zdenka
    Segelmark, Marten
    Hogan, Jonathan
    Morgan, Matthew D.
    Cavero, Teresa
    Eriksson, Per
    Seo, Philip
    Manno, Rebecca L.
    Dale, Jessica
    Harper, Lorraine
    Tesar, Vladimir
    Jayne, David R. W.
    JOURNAL OF NEPHROLOGY, 2016, 29 (02) : 195 - 201
  • [45] The use of rituximab as a single therapy for the treatment of severe recalcitrant pemphigus
    Goolamali, S. I.
    Mufti, G.
    Warnakulasuriya, S.
    du Vivier, A. W. P.
    BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 : 28 - 28
  • [46] A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis
    De Vita, S.
    Quartuccio, L.
    Isola, M.
    Mazzaro, C.
    Scaini, P.
    Lenzi, M.
    Campanini, M.
    Naclerio, C.
    Tavoni, A.
    Pietrogrande, M.
    Ferri, C.
    Mascia, M. T.
    Masolini, P.
    Zabotti, A.
    Maset, M.
    Roccatello, D.
    Zignego, A. L.
    Pioltelli, P.
    Gabrielli, A.
    Filippini, D.
    Perrella, O.
    Migliaresi, S.
    Galli, M.
    Bombardieri, S.
    Monti, G.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (03): : 843 - 853
  • [47] Rituximab in severe, treatment-refractory interstitial lung disease
    Keir, Gregory J.
    Maher, Toby M.
    Ming, Damien
    Abdullah, Reza
    de Lauretis, Angelo
    Wickremasinghe, M.
    Nicholson, Andrew G.
    Hansell, David M.
    Wells, Athol U.
    Renzoni, Elisabetta A.
    RESPIROLOGY, 2014, 19 (03) : 353 - 359
  • [48] SUCCESSFUL TREATMENT OF TYPE II CRYOGLOBULINAEMIA CAUSING ACUTE KIDNEY INJURY WITH PLASMA EXCHANGE AND RITUXIMAB IN SETTING OF SJOGREN'S SYNDROME
    Lee, Chiang Sheng
    Pasalic, Alen
    Tan, Rachel Yi Ping
    Li, Jordan
    NEPHROLOGY, 2022, 27 : 80 - 80
  • [49] Severe hematological side effects following Rituximab therapy in children
    Larrar, Sophie
    Guitton, Corinne
    Willems, Marjolaine
    Bader-Meunier, Brigitte
    HAEMATOLOGICA, 2006, 91 : 101 - 102
  • [50] Rituximab in Severe Pemphigus
    Schmidt, Enno
    Goebeler, Matthias
    Zillikens, Detlef
    CONTEMPORARY CHALLENGES IN AUTOIMMUNITY, 2009, 1173 : 683 - 691